Valuation: Bayer S.A.

Market Cap 294M 85.26M 76.49M 70.72M 64.05M 120M 8.12B 121M 846M 337M 4.25B 320M 313M 13.49B P/E 2022
7.81x
P/E 2023 17.2x
Enterprise Value 327M 94.55M 84.83M 78.43M 71.03M 133M 9.01B 134M 938M 374M 4.71B 355M 347M 14.96B EV / Sales 2022
0.7x
EV / Sales 2023 0.71x
Free-Float
6.09%
Yield 2022 *
-
Yield 2023 -
3 years 14.1
Extreme 14.1
20.1
5 years 14.1
Extreme 14.1
20.1
10 years 13.75
Extreme 13.75
20.1
Manager TitleAgeSince
Chief Executive Officer - 2020-03-31
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2020-03-31
Chairman - 2021-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%+41.84% 85.39M
+2.63%+2.30%+27.07%+39.56% 68.91B
+1.38%+0.40%+21.75%+27.45% 50B
-4.17%-6.27%-7.63%+19.96% 15.54B
-0.12%+1.80%+31.98%+74.04% 13.78B
-0.93%+11.85%+157.53%+16.63% 10.95B
-0.92%+0.10%+26.74%-9.73% 10.12B
+1.72%+2.91%+35.31%+37.48% 10.01B
-0.84%-2.92%+6.75% - 8.77B
+0.53%-3.02%-22.23%+7.92% 7.29B
Average -0.13%+0.27%+27.73%+28.35% 19.54B
Weighted average by Cap. +0.75%-0.08%+28.25%+31.87%

Financials

2022 2023
Net sales 376M 109M 97.73M 90.35M 81.83M 153M 10.37B 155M 1.08B 430M 5.43B 409M 400M 17.23B 338M 97.72M 87.67M 81.06M 73.41M 137M 9.31B 139M 969M 386M 4.87B 367M 359M 15.46B
Net income 26.58M 7.7M 6.9M 6.38M 5.78M 10.8M 733M 10.93M 76.32M 30.4M 384M 28.88M 28.27M 1.22B 12.04M 3.49M 3.13M 2.89M 2.62M 4.89M 332M 4.95M 34.57M 13.77M 174M 13.08M 12.81M 552M
Net Debt 56.7M 16.42M 14.73M 13.62M 12.33M 23.04M 1.56B 23.32M 163M 64.85M 818M 61.61M 60.31M 2.6B 32.11M 9.3M 8.34M 7.71M 6.98M 13.05M 885M 13.2M 92.19M 36.72M 463M 34.88M 34.15M 1.47B
Projected Income Statement - Annual - Bayer S.A.
Logo Bayer S.A.
Bayer SA is a Peru-based company principally engaged in the distribution and sale of chemicals, food colorings, pharmaceutical, veterinary and phytosanitary products. The Company’s business is structured in three areas: Bayer HealthCare, which comprises the commercialization of drugs used in the diagnostic, prevention and treatment of human diseases, as well as veterinary medical supplies; Bayer CropScience, which focuses on the marketing of crop and seeds protection products, biological control of crop parasites and plagues and other products used in the agricultural sector, and Bayer MaterialScience, which includes the import, distribution and sale of high-performance plastics and polymers used in the production of lacquers, adhesives and insulation materials. As of December 31, 2011, Bayer Gesellschaft fuer Beteiligungen mbH was the Company’s majority shareholder with 86.36% of its interest.
Employees
-
  1. Stock Market
  2. Stocks
  3. BAYERI1 Stock